CEUS is a safer, less expensive option for diagnosing focal liver disease.
Contrast-enhanced ultrasound (CEUS) is a safer, less costly option than CT and MRI when it comes to the accurate diagnosis of some types of liver cancer, according to recent research.
In a study published recently in Hepatoma Research, a team of investigators from the University of Calgary outlined some the unique advantages that CEUS offers when characterizing focal liver disease.
“CEUS provides for the determination of malignancy and allows excellent differential diagnosis of a focal liver mass,” said lead study author Stephanie Wilson, M.D., chair of the University of Calgary radiology department. “CEUS regularly resolves an indeterminate result on CT/MRI and is exceptional as a problem-solving tool in liver imaging.”
Routinely, she said, CEUS demonstrates comparable performance to CT and MRI with the characterization and prediction of malignancy.
To determine the details of CEUS’ capabilities, Wilson’s team analyzed the results of a multi-center trial that included 1,349 patients. The study, they said, revealed no statistically significant difference between CEUS and spiral CT in differentiating between benign and malignant liver tumors, as well as tumor specification. The team also examined a meta-analysis of 21 studies that showed CEUS has 88-percent sensitivity, 81-percent specificity, and a diagnostic odds ratio of 38.62. Those studies also showed no statistical differences between contrast-enhanced MRI and contrast-enhanced CT.
In particular, the team noted, CEUS offers several advantages:
Ultimately, the team concluded, CEUS can play a beneficial and effective role in liver cancer diagnostic imaging.
“CEUS has many similarities to contrast-enhanced CT/MRI, but also unique and valuable differences,” they said, “most showing the additional benefit of inclusion of CEUS with CT and MR for liver imaging.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.